These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3933200)

  • 41. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased circulating leptin in alcoholic cirrhosis: relation to release and disposal.
    Henriksen JH; Holst JJ; Møller S; Brinch K; Bendtsen F
    Hepatology; 1999 Jun; 29(6):1818-24. PubMed ID: 10347125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The re-evaluation of sex steroids metabolism in patients with non-alcoholic liver cirrhosis.
    Nakamuta M; Ohashi M; Goto K; Tanabe Y; Hiroshige K; Nawata H
    Fukuoka Igaku Zasshi; 1994 Jun; 85(6):187-94. PubMed ID: 8082866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The immunomodulating and hepatotropic effect of correcting hyperprolactinemia and hypophyseal gonadotropic dysfunction in liver cirrhosis patients].
    Okorokov AN
    Ter Arkh; 1992; 64(2):25-8. PubMed ID: 1509376
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.
    Snyder PJ; Jacobs LS; Utiger RD; Daughaday WH
    J Clin Invest; 1973 Sep; 52(9):2324-9. PubMed ID: 4199418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
    Pósán E; Tornai I; Udvardy M
    Orv Hetil; 1994 Dec; 135(51):2821-4. PubMed ID: 7838517
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Endothelin-1 and -3 plasma concentrations in patients with cirrhosis: role of splanchnic and renal passage and liver function.
    Gerbes AL; Møller S; Gülberg V; Henriksen JH
    Hepatology; 1995 Mar; 21(3):735-9. PubMed ID: 7875671
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hypertyraminemia in cirrhotic patients.
    Faraj BA; Bowen PA; Isaacs JW; Rudman D
    N Engl J Med; 1976 Jun; 294(25):1360-4. PubMed ID: 772438
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pattern of serum amino acids in patients with liver cirrhosis. Influence of shunt surgery and transesophageal sclerotherapy.
    Joelsson B; Hultberg B; Alwmark A; Gullstrand P; Bengmark S
    Scand J Gastroenterol; 1984 Jun; 19(4):547-51. PubMed ID: 6611579
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone.
    Foley TP; Jacobs LS; Hoffman W; Daughaday WH; Blizzard RM
    J Clin Invest; 1972 Aug; 51(8):2143-50. PubMed ID: 4626583
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
    Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J
    J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enhanced external counterpulsation: a new technique to augment renal function in liver cirrhosis.
    Werner D; Trägner P; Wawer A; Porst H; Daniel WG; Gross P
    Nephrol Dial Transplant; 2005 May; 20(5):920-6. PubMed ID: 15788437
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Basal serum prolactin in liver cirrhosis and its clinical significance].
    Dang ZD; Tao JY; Zhu LF
    Zhonghua Nei Ke Za Zhi; 1985 Mar; 24(3):153-4, 190. PubMed ID: 4006606
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hyperprolactinemia in liver diseases. Occurrence, clinical significance, etiology].
    Wernze H; Burghardt W
    Med Klin; 1979 Nov; 74(44):1615-23. PubMed ID: 42843
    [No Abstract]   [Full Text] [Related]  

  • 55. Is serum prolactin of prognostic value in hepatic encephalopathy?
    Nanivadekar SA; Sainani GS
    J Assoc Physicians India; 1988 Mar; 36(3):193-4. PubMed ID: 3182662
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum prolactin in advanced chronic liver disease.
    Ress C; Maeser PA; Tschoner A; Loacker L; Salzmann K; Staudacher G; Melmer A; Zoller H; Vogel W; Griesmacher A; Tilg H; Graziadei I; Kaser S
    Horm Metab Res; 2014 Oct; 46(11):800-3. PubMed ID: 24816831
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Response of prolactin (PRL) to the administration of TRH in male patients with alcoholic cirrhosis: 2. Relation of PRL to diuresis and urine excretion of electrolytes].
    Pérez Alvarez R; Arribas Castrillo JM; Rodrigo Sáez L; García Saavedra L; Sánchez Lombraña JL; Rodríguez García M; García López
    Rev Esp Enferm Apar Dig; 1986 May; 69(5):427-32. PubMed ID: 3090655
    [No Abstract]   [Full Text] [Related]  

  • 58. HYPERTHYROIDISM AND HYPERPROLACTINEMIA: IS THERE ANY ASSOCIATION?
    Sanjari M; Safi Z; Tahroodi KM
    Endocr Pract; 2016 Dec; 22(12):1377-1382. PubMed ID: 27540882
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Prolactin in chronic alcoholic liver diseases with and without gynecomastia].
    Nardoni A; Marchetti E; Geatti O; Di Piazza V; Rossi G; Cedaro P
    Minerva Med; 1985 Jan; 76(1-2):37-42. PubMed ID: 3883240
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum apoproteins A and B and the lecithin: cholesterol acyl transferase activities in liver cirrhosis and hepatic coma patients.
    Nayak SS; Ramani A; Kamath SS; Kundaje GN; Aroor AR
    Biochem Med Metab Biol; 1988 Dec; 40(3):299-304. PubMed ID: 3233186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.